Lecture 8: Androgens and Treatment of Impotence

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/84

encourage image

There's no tags or description

Looks like no tags are added yet.

85 Terms

1
New cards

Anabolic Steroids

-androgen receptor agonists

-effects such as weight gain and increased muscle mass

2
New cards

5alpha-reductase

converts testosterone to DHT

3
New cards

Aromatase

converts testosterone to estradiol

4
New cards

Cholesterol

precursor to steroids

5
New cards

Suppress

Elevated androgens _____________________ the HPG axis

6
New cards

Androgens

Effects:

-growth of penis, scrotum, larynx, skeleton

-development of facial, pubic, and axillary hair

-darkening of skin

-increased muscle mass/strength

-increased RBC production

-libido, fertility, bone mineral density

7
New cards

Androgens

MOA:

-dissociate from SHBG

-enters cells and binds to cytosolic receptors

-hormone-receptor complex dimerizes and enters nucleus

-modulates gene expression

8
New cards

Androgen Replacement Therapy

for hypogonadism and hypopituitarysm prior to adolescene

9
New cards

Androgen Replacement Therapy

Indications:

-gynecologic disorders

-reverse protin loss

-anemia

-osteoporossis

-growth stimulation in delayed puberty

-female to male transsexual gender dysphoria

10
New cards

Danazol

weak androgen with anti-estrogen activity that is used for endometriosis

11
New cards

Androgen Replacement Therapy

Off-label Uses:

-reduce post-partum (with estrogen)

-endometriosis

-Post-menopausal elimination of bleeding and enhancing lipido

-premenopausal in breast tumor chemotherapy

12
New cards

Oral

What Preparation:

-methyltestosterone

-fluoxymesterone

13
New cards

Parenteral

What Preparation:

-testosterone enanthate

-testosterone cypionate

-testosterone propionate

-testosterone undecanoate

14
New cards

Testosterone Propionate

What formulation of Testosterone is NOT recommended due to short duration of action

15
New cards

Testosterone Undecanoate

What formulation of Testosterone is NOT recommended due to association with liver tumors?

16
New cards

-methyltestosterone

-fluoxymesterone

-patient friendly administration

-flexible dosing

-immediate discontinuation

-ineffective androgen effects

-negative lipid effects

-high risk of hepatic adverse effects

17
New cards

Testosterone Undecanoate

-"rollercoaster" pharmacokinetics

-fluctuations in mood, libido

-site rxns

-pulmonary oil microembolism rxn

-higher CV risk than topical products

-good safety porfile

-injections every 10 weeks

18
New cards

-testosterone enanthate

-testosterone cypionate

-"rollercoaster" pharmacokinetics

-fluctuations in mood, libido

-site rxns

-pulmonary oil microembolism rxn

-higher CV risk than topical products

-good safety profile

-inexpesive

-injections every 2-4 weeks

19
New cards

Gels/Solutions

What preparation of testosterone:

-cross exposure of product

-apply deoderant first

-expensive

-daily administration

-higher potency and small surface area

20
New cards

Pellet

What preparation of testosterone:

-unpredictable pharmacokinetics

-local site reactions

-difficult dosing regimen

-requirement of incision

21
New cards

Testosterone Undecanoate

available only through a restricted program called the Aveed(R) REMS Program due to the risk of serious pulmonary oil microembolism (POME) reactions (urge to cough, dyspnea, throat tightening, chest pain, dizziness, syncope) and potentially life-threatening anaphylaxis

22
New cards

Testosterone Replacement Therapy

CIs:

-breast or prostate cancer

-BPH

-pregnancy

23
New cards

BP increases

BBW for testosterone undecanoate and SC testosterone encanthate

24
New cards

Testosterone Replacement Therapy

-can increase BP

-can cause fluid retention and heart failure

-dont use in men who have experienced an MI or stroke within the past 6 months

-may worsen sleep apnea

25
New cards

Testosterone Replacement Therapy

Adverse effects

• Sodium retention: Edema, weight gain

• Acne, gynecomastia, hair loss/balding, infertility (azoospermia and decreased testicular size)

• Worsened sleep apnea, elevated blood pressure, decrease total cholesterol and HDL

• Oral: hepatotoxicity

• Parenteral: polycythemia

• Topical: site reactions

26
New cards

-Warfarin (increased bleeding)

-Paclitaxel (toxicity)

-Bupropion (lowered seizure threshold)

Drug interactions with Testosterone replacement therapy

27
New cards

3 Month

Testosterone therapies in any route/dose should have a __________________ trial before determining response

28
New cards

GnRH Agonists

-antiandrogen option for advaned prostatic carcinoma

-goserelin, nafarelin, leuprolide

29
New cards

Steroid Synthesis Inhibitors

-antiadrogen option for advaned prostatic carcinoma

-ketoconazole, spironolactone, abiraterone, finasteride, dutasteride

30
New cards

Androgen Receptor Inhibitors

-antiadrogen option for advaned prostatic carcinoma

-cyproterone, flutamide, bicalutamide, nilutamide, enzalutamide, spironolactone, apalutamide, and darolutamide

31
New cards

Leoprolide

-produces an initial increase in LH and FSH which leads to a transient increase testosterone and dihydrotestosterone (in males) and estrone and estradione (in premenopausal females).

-receptor inhibitor

-suppresses ovarian and testicular steroidogenesis

32
New cards

• Dopamine exerts a proerectogenic effect

• α2-adrenergic stimulation (makes penis flaccid)

Integration of external stimuli via medial pre-optic area of the hypothalamus

33
New cards

• Inhibitory sympathetic neurons (T11-L2)

• Proerectogenic parasympathetic neurons (S2-S4)

• Proerectogenic somatic neurons (S2-S4)

nerve impulses travel to the penis via what?

34
New cards

Nitric Oxide and cGMP

Androgen receptors in the penile arterial endothelium may increase cavernosal levels of ______________________ and __________________

35
New cards

Flaccid

arterial flow into and venous outflow from the corpora are balanced

36
New cards

Erectile Phase

-arterial blood flow increases, and blood fills the sinusoids within the corpora

-• Swelling and elongation

• Prolongation or sustainment of erection occurs by

venous outflow occlusion from the corpora

37
New cards

Two; One

How many:

_________ corpora cavernosa & ___________ corpus spongiosum

38
New cards

Acetylcholine (ACh)

what neurotransmitter enhances nitric oxide production?

39
New cards

Prostaglandin E

enhances the activity of adenyl cyclase resulting in smooth muscle relaxation via vasodilation and enhanced arterial blood flow into the corpora

40
New cards

-Anti-androgens

-5alpha-reductase inhibitors

-Anti-hypertensives

-Anti-arrhythmics

-Psychotropics

Medications that can contribute to ED

41
New cards

-Smoking

-Diabetes

-Hypertension

-Obesity

most common preventable ED risk factors

42
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

first line for ED with complete cardio risk assessment

43
New cards

Alprostadil

what drug is considered if PDE5is are ineffective or cannot be used?

44
New cards

Coronary Artery Disease

ED and ___________________ frequently coexist

45
New cards

Cardiovascular Status

It is prudent to evaluate a patient's ____________________ before initiating treatment of ED with a PDE5 inhibitor

46
New cards

-Testosterone Replacement

-Vaccuum Erection Devices

-Surgery

if PDE-5is and Alprostadil dont work, what are your other options?

47
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

-Avanafil

-Sildenafil

-Tadalafil

-Vardenafil

48
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

"-afil"

49
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

Indications:

• Erectile dysfunction, pulmonary arterial hypertension

• Off label: Raynaud phenomenon

• 1st line therapy due to onset of action, efficacy,

discretion with use, and level of invasiveness

50
New cards

Reversible

Phosphodiesterase-5 inhibitors (PDE5Is) work via competitve __________________ inhibition

51
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

- Decreases degradation of cGMP to enhance smooth muscle relaxation and inflow of blood into corpus

cavernosum

• Also inhibit phosphodiesterase in non-genital tissues

52
New cards

Sildenafil

-PDE5 and PDE-6 inhibition

-absorption impaired by fatty meals

-take 30-60 min before sexual activity

-take on empty stomach

-do not use in severe renal/hepatic disease

53
New cards

Vardenafil

-PDE5 and minimal PDE-6 inhibition

-absorption impaired by fatty meals

-take 30-60 min before sexual activity

-take on empty stomach

-do not use in severe renal/hepatic disease

54
New cards

Tadalafil

-PDE5 and PDE11 inhibtion

-take 2 hours before sexual activity

-slower onset

-do not use in severe renal/hepatic disease

55
New cards

Avanafil

-PDE5, minimal PDE6 and 11 inhibition

-take 30-60 min before sexual activity

-do not use in severe renal/hepatic disease

56
New cards

PDE-6

-Phosphotiesterase isoenzyme found in rods and cones of the eye.

-Drug inhibition assoc with blurred vision and cyanopsia

57
New cards

PDE-11

-Phosphotiesterase isoenzyme found in striated muscle

-inhibtiion assoc with myalgia and muscle pain

58
New cards

Tadalafil

which PDE5i has the msot inhibitory action of PDE-11

59
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

Contraindications:

• Regular or intermittent concurrent use of organic nitrates in any form

• Concomitant use of riociguat

60
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

Drug interactions:

• Nitrates

• Riociguat

• Antihypertensives

• Alpha antagonists

• CYP3A4 inhibitors

• Vardenafil + class I or III

antiarrhythmics

61
New cards

Phosphodiesterase-5 inhibitors (PDE5Is)

Adverse effects

• Common: headache, facial flushing,

dyspepsia, nasal congestion, dizziness

• Priapism (direct patient to ED)

• Serious: Non-arteritic anterior ischemic

optic neuropathy, hearing loss

62
New cards

Hypotension

adverse effect assoc with both Sildenafil and Vardenafil

63
New cards

Visual Disturbances

Adverse effect assoc with Sildenafil, Vardenafil, and Avanafil

64
New cards

Alprostadil

-PDE5i

• Indication: Erectile dysfunction

• Off label: Raynaud phenomenon

65
New cards

Alprostadil

• Prostaglandin E1

• Stimulates adenyl cyclase to increase cAMP, which ↓ intracellular calcium concentration and causes smooth muscle relaxation

• ↑ blood flow to and blood filling of the corpora

66
New cards

Alprostadil

Contraindications

• Priapism predisposing conditions (hyperviscosity syndromes like sickle cell anemia or trait, multiple myeloma, leukemia)

• Anatomical deformation or fibrotic conditions of the penis (angulation, cavernosal fibrosis, or Peyronie disease)

• Penile implants

67
New cards

Alprostadil

Contraindications

• Priapism predisposing conditions

(hyperviscosity syndromes like sickle cell

anemia or trait, multiple myeloma, leukemia)

• Anatomical deformation or fibrotic conditions

of the penis (angulation, cavernosal fibrosis,

or Peyronie disease)

• Penile implants

68
New cards

Intraurethral Injection

-preparation of Alprostadil

-rapidly absorbed

-systemically absorbed and deactivated by first pass through lungs

69
New cards

Intraurethral Injection

-preparation of Alprostadil

CIs:

• Patients with urethral stricture or urethritis or curvature

• Men who are prone to venous thrombosis or who have a hyperviscosity syndrome (sickle cell anemia or trait, thrombocythemia, polycythemia, multiple myeloma) predisposing them to priapism

• Use in men for whom sexual activity is inadvisable

• Pregnancy in female partner without condom barrier

70
New cards

• Urethral injury, stricture, and difficulty voiding

• Urethral pain

• Vaginal pain, itching, burning in female sexual partner

• Rare: priapism, syncope, dizziness

AEs assoc with intraurethral injection of Alprostadil

71
New cards

• Local anesthesia

• Priapism not due to intracavernosal injection: penile aspiration

• Priapism secondary to intracavernosal injection: intracavernosal injection of sympathomimetic agent (phenylephrine)

Management of ischemic priapism

72
New cards

Vacuum Erection Device (VED)

• Cylinder attached to pump which creates negative pressure chamber

• Promotes arterial blood flow into corpora cavernosa

• Constriction bands or tension rings can be applied to the base of the penis to prolong erection

73
New cards

Vacuum Erection Device (VED)

-For pts with CIs or lack of response to PDE-5

inhibitors, or patient preference

• Combination therapy

• Nondescript; often discontinued by patients

-AEs: • Pain, bruising, injury, discoloration

74
New cards

• Penile curvature, sickle cell disease, history of priapism

• Caution in patients taking warfarin

CIs for Vacuum Erection Device (VED)

75
New cards

Hypogonadism

-deficiencies in gametogenesis and/or the secretion of gonadal hormones

• Low circulating levels of testosterone (defined as

76
New cards

Primary

_________________ Hypogonadism:

testicular failure

77
New cards

Secondary

_______________ Hypogonadism:

hypothalamic or pituitary dysfunction

78
New cards

Hypogonadism

Main Signs:

Decreased libido, erectile dysfunction, and loss of spontaneous morning erections

-decreased free Testosterone

79
New cards

Yohimbine

• Central α2-adrenergic antagonist; ↑ catecholamines and improves mood

• May have peripheral proerectogenic effects; may ↓ peripheral α adrenergic tone, causing

predominant cholinergic tone with a vasodilatory response

• AE include anxiety, insomnia, tachycardia, & HTN

80
New cards

Papaverine

• Nonspecific PDE5 inhibitor

-used as a vasodilator for arterial vasospasm

• Intracavernosal injection

81
New cards

Phentolamine

• Competitive nonselective α-adrenergic blocking agent

-used for extravasation of vasopressors and for settings of catecholamine excess

• Intracavernosal injection

82
New cards

Alprostadil

AEs:

• Local injection site reactions: penile pain, bruising, fibrosis leading to curvature

• Priapism, hypotension, dizziness

83
New cards

Alprostadil

84
New cards

Alprostadil

Contraindications

• Priapism predisposing conditions

(hyperviscosity syndromes like sickle cell

anemia or trait, multiple myeloma, leukemia)

• Anatomical deformation or fibrotic conditions

of the penis (angulation, cavernosal fibrosis,

or Peyronie disease)

• Penile implants

85
New cards

Alprostadil